"Oncogene Proteins, Viral" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Products of viral oncogenes, most commonly retroviral oncogenes. They usually have transforming and often protein kinase activities.
Descriptor ID |
D009856
|
MeSH Number(s) |
D12.776.624.664.520 D12.776.964.700
|
Concept/Terms |
Oncogene Proteins, Viral- Oncogene Proteins, Viral
- Viral Oncogene Proteins
- Viral Transforming Proteins
- Transforming Proteins, Viral
- v-onc Proteins
- v onc Proteins
|
Below are MeSH descriptors whose meaning is more general than "Oncogene Proteins, Viral".
Below are MeSH descriptors whose meaning is more specific than "Oncogene Proteins, Viral".
This graph shows the total number of publications written about "Oncogene Proteins, Viral" by people in this website by year, and whether "Oncogene Proteins, Viral" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 0 | 1 | 1 |
2002 | 1 | 1 | 2 |
2004 | 2 | 0 | 2 |
2006 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Oncogene Proteins, Viral" by people in Profiles.
-
Anobile JM, Arumugaswami V, Downs D, Czymmek K, Parcells M, Schmidt CJ. Nuclear localization and dynamic properties of the Marek's disease virus oncogene products Meq and Meq/vIL8. J Virol. 2006 Feb; 80(3):1160-6.
-
Heussinger N, Büttner M, Ott G, Brachtel E, Pilch BZ, Kremmer E, Niedobitek G. Expression of the Epstein-Barr virus (EBV)-encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma. J Pathol. 2004 Jun; 203(2):696-9.
-
Belcastro M, Miller MR, Flynn DC, Soisson AP. C/EBPbeta activity and HPV-16 E6/E7 mRNA expression are not altered by imiquimod (ALDARA) in human cervical cancer cells in vitro. Gynecol Oncol. 2004 Feb; 92(2):660-8.
-
Shivakumar L, Minna J, Sakamaki T, Pestell R, White MA. The RASSF1A tumor suppressor blocks cell cycle progression and inhibits cyclin D1 accumulation. Mol Cell Biol. 2002 Jun; 22(12):4309-18.
-
Manara MC, Perbal B, Benini S, Strammiello R, Cerisano V, Perdichizzi S, Serra M, Astolfi A, Bertoni F, Alami J, Yeger H, Picci P, Scotlandi K. The expression of ccn3(nov) gene in musculoskeletal tumors. Am J Pathol. 2002 Mar; 160(3):849-59.
-
Razani B, Altschuler Y, Zhu L, Pestell RG, Mostov KE, Lisanti MP. Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation. Biochemistry. 2000 Nov 14; 39(45):13916-24.
-
Flomenberg P, Szmulewicz J, Gutierrez E, Lupatkin H. Role of the adenovirus E3-19k conserved region in binding major histocompatibility complex class I molecules. J Virol. 1992 Aug; 66(8):4778-83.
-
Flomenberg PR, Chen M, Horwitz MS. Characterization of a major histocompatibility complex class I antigen-binding glycoprotein from adenovirus type 35, a type associated with immunocompromised hosts. J Virol. 1987 Dec; 61(12):3665-71.